Table 2 Susceptibility and resistance profile of M. tuberculosis genotypes to first and second line anti-mycobacterium drugs
| Â | TB resistance profiles to first line (FL) drugs | TB resistance profiles to second line (SL) drugs | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Parameter | INH | RIF | STM | EMB | MDR | ETHIO | OFL | CAP | AMIK | Pre-XDR | XDR |
Age | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) |
≤ 20 | 23 (12.1) | 22 (11.6) | 12 (6.3) | 2 (1.1) | 22 (11.6) | 2 (1.1) | 1 (0.53) | 2 (1.1) | 4 (2.1) | 2 (1.1) | 23 (12.1) |
21–40 | 114 (60) | 114 (60) | 73 (38.4) | 20 (10.5) | 114 (60) | 23 (12.1) | 30 (15.8) | 7 (3.6) | 58 (30.5) | 18 (9.4) | 83 (43.7) |
41–60 | 46 (24.2) | 46 (24.2) | 21 (11.1) | 3 (1.58) | 46 (24.2) | 5 (2.63) | 3 (1.6) | 4 (2.1) | 18 (9.5) | 12 (6.3) | 46 (24.2) |
≥61 | 5 (2.6) | 5 (2.6) | 2 (1.1) | 0 (0) | 5 (2.6) | 2 (1.1) | 2 (1.1) | 0 (0) | 3 (1.6) | 1 (0.53) | 5 (2.6) |
Total | 188 (98.9) | 187 (98.4) | 108 (56.8) | 25 (12.7) | 187 (98.4) | 32 (16.8) | 36 (18.9) | 13 (6.8) | 83 (43.7) | 33 (17.4) | 157 (82.6) |
Gender | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Male | 85 (43) | 84 (42.6) | 47 (23.5) | 8 (4) | 84 (42.6) | 17 (8.6) | 14 (7.1) | 5 (2.5) | 36 (18.2) | 17 (8.6) | 85 (38) |
Female | 105 (55.3) | 105 (55.3) | 60 (31.6) | 10 (5.3) | 105 (55.3) | 15 (7.9) | 22 (11.6) | 8 (4.21) | 47 (24.7) | 16 (8.42) | 85 (44.7) |
Total | 190 (100%) | 189 (99.5) | 107 (56.3) | 18 (9.5) | 189 (99.5) | 32 (16.8) | 36 (18.9) | 13 (6.8) | 83 (43.7) | 33 (17.4) | 157 (82.6) |